83 FR 9029 - Bulk Manufacturer of Controlled Substances Application: Stepan Company
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 42 (March 2, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 42 (March 2, 2018)
| Page Range | 9029-9029 | |
| FR Document | 2018-04269 |
[Federal Register Volume 83, Number 42 (Friday, March 2, 2018)] [Notices] [Page 9029] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-04269] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Stepan Company ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before May 1, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Diversion Control Division (``Deputy Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on January 22, 2018, Stepan Company, 100 W Hunter Ave., Maywood, NJ 07607 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Drug Controlled substance code Schedule ------------------------------------------------------------------------ Cocaine................................ 9041 II Ecgonine............................... 9180 II ------------------------------------------------------------------------ The company plans to manufacture the above-listed controlled substances in bulk for sale to its customers. No other activities for these drug codes are authorized for this registration. Dated: February 20, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-04269 Filed 3-1-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 42 / Friday, March 2, 2018 / Notices 9029
institution of this investigation in the evaluations relating to the programs, SUPPLEMENTARY INFORMATION: The
Federal Register on April 29, 2009 (47 personnel, and operations of the Attorney General has delegated his
FR 19592), and published notice of the Commission including under 5 U.S.C. authority under the Controlled
Commission’s invitation to submit Appendix 3; or (ii) by U.S. government Substances Act to the Administrator of
information in connection with the employees and contract personnel for the Drug Enforcement Administration
eighth annual report in the Federal cybersecurity purposes. The (DEA), 28 CFR 0.100(b). Authority to
Register on May 1, 2017 (82 FR 20375). Commission will not otherwise disclose exercise all necessary functions with
Written Submissions: Interested any confidential business information in respect to the promulgation and
parties are invited to file written a manner that would reveal the implementation of 21 CFR part 1301,
submissions concerning this ninth operations of the firm supplying the incident to the registration of
annual review. All written submissions information. manufacturers, distributors, dispensers,
should be addressed to the Secretary, Summary of Written Submissions: importers, and exporters of controlled
and all such submissions should be The Commission intends to publish a substances (other than final orders in
received no later than 5:15 p.m., April summary of the written submissions of connection with suspension, denial, or
30, 2018. All written submissions must interested persons in an appendix to its revocation of registration) has been
conform to the provisions of section report. Persons wishing to have a redelegated to the Deputy Assistant
201.8 of the Commission’s Rules of summary of their position included in Administrator of the DEA Diversion
Practice and Procedure (19 CFR 201.8). the appendix should include a summary Control Division (‘‘Deputy Assistant
Section 201.8 and the Commission’s with their written submission. The Administrator’’) pursuant to section 7 of
Handbook on Filing Procedures require summary may not exceed 500 words, 28 CFR part 0, appendix to subpart R.
that interested parties file documents should be in MSWord format or a format In accordance with 21 CFR
electronically on or before the filing that can be easily converted to MSWord, 1301.33(a), this is notice that on January
deadline and submit eight (8) true paper and should not include any confidential 22, 2018, Stepan Company, 100 W
copies by 12:00 p.m. eastern time on the business information. The summary will Hunter Ave., Maywood, NJ 07607
next business day. If confidential be published as provided if it meets applied to be registered as a bulk
treatment of a document is requested, these requirements and is germane to manufacturer of the following basic
interested parties must file, at the same the subject matter of the investigation. classes of controlled substances:
time as the eight paper copies, at least In the appendix the Commission will
four (4) additional true paper copies in identify the name of the organization Drug
which the confidential information Controlled substance Schedule
furnishing the summary, and will code
must be deleted (see the following include a link to the Commission’s
paragraphs for further information Cocaine .......................... 9041 II
Electronic Document Information Ecgonine ......................... 9180 II
regarding confidential business System (EDIS) where the full written
information). Persons with questions submission can be found.
regarding electronic filing should The company plans to manufacture
contact the Office of the Secretary, By order of the Commission. the above-listed controlled substances
Docket Services Division (202–205– Issued: February 27, 2018. in bulk for sale to its customers. No
1802). Lisa R. Barton, other activities for these drug codes are
Confidential Business Information. Secretary to the Commission. authorized for this registration.
Any submissions that contain [FR Doc. 2018–04308 Filed 3–1–18; 8:45 am] Dated: February 20, 2018.
confidential business information must BILLING CODE 7020–02–P Susan A. Gibson,
also conform to the requirements of Deputy Assistant Administrator.
section 201.6 of the Commission’s Rules
[FR Doc. 2018–04269 Filed 3–1–18; 8:45 am]
of Practice and Procedure (19 CFR
BILLING CODE 4410–09–P
201.6). Section 201.6 of the rules DEPARTMENT OF JUSTICE
requires that the cover of the document
and the individual pages be clearly Drug Enforcement Administration
marked as to whether they are the
‘‘confidential’’ or ‘‘non-confidential’’ DEPARTMENT OF LABOR
[Docket No. DEA–392]
version, and that the confidential Office of the Secretary
business information is clearly Bulk Manufacturer of Controlled
identified by means of brackets. All Substances Application: Stepan Agency Information Collection
written submissions, except for Company Activities; Submission for OMB
confidential business information, will Review; Comment Request;
be made available for inspection by ACTION: Notice of application.
Agreement and Undertaking
interested parties.
The Commission will not include any DATES: Registered bulk manufacturers of ACTION:Notice of availability; request
confidential business information in the the affected basic classes, and for comments.
report that it sends to the Committees or applicants therefore, may file written
makes available to the public. However, comments on or objections to the SUMMARY: The Department of Labor
all information, including confidential issuance of the proposed registration in (DOL) is submitting the Office of
business information, submitted in this accordance with 21 CFR 1301.33(a) on Workers’ Compensation Programs
daltland on DSKBBV9HB2PROD with NOTICES
investigation may be disclosed to and or before May 1, 2018. (OWCP) sponsored information
used: (i) By the Commission, its ADDRESSES: Written comments should collection request (ICR) titled,
employees and offices, and contract be sent to: Drug Enforcement ‘‘Agreement and Undertaking,’’ to the
personnel (a) for developing or Administration, Attention: DEA Federal Office of Management and Budget
maintaining the records of this or a Register Representative/DRW, 8701 (OMB) for review and approval for
related proceeding, or (b) in internal Morrissette Drive, Springfield, Virginia continued use, without change, in
investigations, audits, reviews, and 22152. accordance with the Paperwork
VerDate Sep<11>2014 18:10 Mar 01, 2018 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1](https://thefederalregister.org/doc/83_FR_9071/page/1.svg)
Document Created: 2018-03-01 23:57:14
Document Modified: 2018-03-01 23:57:14
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before May 1, 2018. | |
| FR Citation | 83 FR 9029 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR